The drug’s developer, Cereno Scientific, believes its oral therapy could have a major impact on the pulmonary arterial ...

New research could pave the way toward a new method of pulmonary arterial hypertension diagnosis and monitoring.

Cereno Scientific (Nasdaq First North: CRNO B), an innovative biotech pioneering treatments to enhance and extend life for people with rare cardiovascular and pulmonary diseases, today announced that ...

Pulmonary arterial hypertension is a disease in which ... Serotonin can promote both pulmonary vasoconstriction and pulmonary vascular remodeling and is thought to be involved in the pathobiology ...

Pulmonary arterial hypertension (PAH) is a vascular remodeling disease that pathologically increases pulmonary vascular resistance. Ultimately, this leads to right ventricular failure and ...

Merck , known as MSD outside of the United States and Canada, today announced that new clinical and outcomes research data will be presented at the American College of Cardiology's Annual Scientific ...

More information: Liana Hatoum et al, Bone marrow transplant protects mice from sickle cell–mediated large artery remodeling, Science Translational Medicine (2025). DOI: 10.1126/scitranslmed.adp7690 ...

“CS014 demonstrates a strong efficacy for reversal of pulmonary vascular remodeling in a translationally validated disease animal model in pulmonary arterial hypertension — the Sugen/Hypoxia ...

BACKGROUND: Despite the high morbidity and mortality of heart failure with preserved ejection fraction (HFpEF), treatment ...

Researchers from Osaka University have discovered that tricaprin enhances survival in patients with a newly identified heart ...

A new study published in the journal of Cardiology in the Young showed that although vitamin D deficiency is frequent and ...